Clinical Trial Update: Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing Ulipristal acetate to a gonadotropin-releasing hormone analogue before hysteroscopic resection of uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Gonadotropin-releasing hormone analogue (gonadotropin-releasing hormone analogue)
• Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: University Magna Graecia | Conditions: Fibroid | Phase 4 | Status: UNKNOWN